These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4696107)

  • 1. In vivo activation by benzotropine of dopamine release and synthesis in the caudate nucleus.
    Cheramy A; Gauchy G; Glowinski J; Besson MJ
    Eur J Pharmacol; 1973 Feb; 21(2):246-8. PubMed ID: 4696107
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of benztropine and desipramine on the high affinity uptake of paratyramine in slices of the caudate nucleus and hypothalamus.
    Petrali EH
    Neurochem Res; 1980 Mar; 5(3):297-300. PubMed ID: 7374883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benztropine-induced release of dopamine from brain in vivo.
    Goodale DB; Moore KE
    Neuropharmacology; 1975 Aug; 14(8):585-9. PubMed ID: 1178116
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Adv Neurol; 1974; 5():69-78. PubMed ID: 4155237
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):101-5. PubMed ID: 4267960
    [No Abstract]   [Full Text] [Related]  

  • 6. An adaptation of the push-pull cannula method to study the in vivo release of (3H)dopamine synthesized from (3H)tyrosine in the cat caudate nucleus: effects of various physical and pharmacological treatments.
    Nieoullon A; Cheramy A; Glowinski J
    J Neurochem; 1977 Apr; 28(4):819-28. PubMed ID: 894289
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.
    Besson M; Cheramy A; Feltz P; Glowinski J
    Brain Res; 1971 Sep; 32(2):407-24. PubMed ID: 4400012
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of various antiparkinsonian agents as releasing agents and uptake inhibitors for 3H-dopamine in slices of rat neostriatum.
    Orlansky H; Heikkila RE
    Eur J Pharmacol; 1974 Dec; 29(2):284-91. PubMed ID: 4442446
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei.
    Chesselet MF; Reisine TD
    J Neurosci; 1983 Jan; 3(1):232-6. PubMed ID: 6130131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous determination of 3H-labelled 3,4-dihydroxyphenethylamine (dopamine) synthesis and release in the cat caudate nucleus in vivo.
    Chéramy A; Glowinski J; Besson MJ; Gauchy C
    Biochem Soc Trans; 1976; 4(1):20-2. PubMed ID: 1001628
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of dopamine in vivo from cat substantia nigra.
    Nieoullon A; Cheramy A; Glowinski J
    Nature; 1977 Mar; 266(5600):375-7. PubMed ID: 859606
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat.
    Nieoullon A; Cheramy A; Leviel V; Glowinski J
    Eur J Pharmacol; 1979 Jan; 53(3):289-96. PubMed ID: 32060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of chronic dopamine release from the caudate nucleus of the Macaca mulatta.
    Gauchy C; Bioulac B; Cheramy A; Besson MJ; Glowinski J; Vincent JD
    Brain Res; 1974 Sep; 77(2):257-68. PubMed ID: 4211990
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action CDP-choline in parkinsonism.
    Manaka S; Sano K; Fuchinoue T; Sekino H
    Experientia; 1974 Feb; 30(2):179-80. PubMed ID: 4814607
    [No Abstract]   [Full Text] [Related]  

  • 18. Postnatal development of benztropine-induced locomotor stimulation: evidence for an anticholinergic mechanism of action.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):313-20. PubMed ID: 4734004
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo release of endogenously synthesized catecholamines from the cat brain evoked by electrical stimulation and by d-amphetamine.
    Chiueh CC; Moore KE
    J Neurochem; 1974 Jul; 23(1):159-68. PubMed ID: 4852387
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of catechol-O-methyl transferase inhibitors on behavior and dopamine metabolism.
    McKenzie GM
    Adv Biochem Psychopharmacol; 1974; 12(0):339-51. PubMed ID: 4419524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.